GLP Watchdog

Ivy Rx vs Wisp

Neither Ivy Rx nor Wisp has an FDA warning letter on record. No price lines up like for like: Ivy Rx and Wisp publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Ivy Rx / Wisp

Ivy Rx logo

Ivy Rx

7.3/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$197/moCompounded semaglutide injection
$225/moCompounded oral semaglutide
States
All 50 states
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Ivy Rx
Visit Wisp

Neither Ivy Rx nor Wisp pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, Wisp 7.1. How we are paid

What the record shows

  1. 01

    Neither Ivy Rx nor Wisp has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like: Ivy Rx and Wisp publish prices for different products.

  4. 04

    Only Ivy Rx lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only Wisp lists a price for compounded oral semaglutide.

  5. 05

    Ivy Rx covers 11 states Wisp does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Ivy Rx

Wisp

Compounded semaglutide injection

$197/mo

$2,364 a year

Not sold or not priced
Compounded tirzepatide injection

$297/mo

$3,564 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$225/mo

$2,700 a year

Price includes
Medication, clinician visits, shipping
Medication, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
Not stated
Refunds
All transactions are final; no returns
All sales are final
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Ivy Rx: July 10, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Ivy Rx

7.3/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Wisp does not price
  • Lists 50 states against 39
  • Names no compounding pharmacy
Visit Ivy Rx

The case for Wisp

7.1/10
  • Sells compounded oral semaglutide, which Ivy Rx does not price
  • Names no compounding pharmacy
Visit Wisp

Scores

Ivy Rx 7.3 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
8.2

Support10%

7.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

Ivy Rx vs Wisp: questions

Neither Ivy Rx nor Wisp has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like: Ivy Rx and Wisp publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Ivy Rx states you can cancel at any time; refunds: all transactions are final; no returns. Wisp states you can cancel at any time; refunds: all sales are final.
Neither Ivy Rx nor Wisp pays us. Links to them earn nothing. Scores: Ivy Rx 7.3, Wisp 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register